{"id":1125189,"date":"2024-05-23T07:53:39","date_gmt":"2024-05-23T11:53:39","guid":{"rendered":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/uncategorized\/bone-marrow-homing-lipid-nanoparticles-for-genome-editing-in-diseased-and-malignant-haematopoietic-stem-cells-nature-com\/"},"modified":"2024-05-23T07:53:39","modified_gmt":"2024-05-23T11:53:39","slug":"bone-marrow-homing-lipid-nanoparticles-for-genome-editing-in-diseased-and-malignant-haematopoietic-stem-cells-nature-com","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/genome\/bone-marrow-homing-lipid-nanoparticles-for-genome-editing-in-diseased-and-malignant-haematopoietic-stem-cells-nature-com\/","title":{"rendered":"Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells – Nature.com"},"content":{"rendered":"

Laurenti, E. & Gottgens, B. From haematopoietic stem cells to complex differentiation landscapes. Nature 553, 418426 (2018). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Bauer, T. R. Jr. et al. Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy. Blood 108, 33133320 (2006). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Blaese, R. M. et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4years. Science 270, 475480 (1995). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Boztug, K. et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N. Engl. J. Med. 363, 19181927 (2010). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Cowan, M. J. et al. Early outcome of a phase I\/II clinical trial (NCT03538899) of gene-corrected autologous CD34+ hematopoietic cells and low-exposure busulfan in newly diagnosed patients with Artemis-deficient severe combined immunodeficiency (ART-SCID). Biol. Blood Marrow Transpl. 26, S88S89 (2020). <\/p>\n

Article Google Scholar <\/p>\n

Gaspar, H. B. et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364, 21812187 (2004). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Kanter, J. et al. Biologic and clinical efficacy of LentiGlobin for sickle cell disease. N. Engl. J. Med. 386, 617628 (2022). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Kohn, L. A. & Kohn, D. B. Gene therapies for primary immune deficiencies. Front. Immunol. 12, 648951 (2021). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Kondo, M. et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev. Immunol. 21, 759806 (2003). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Locatelli, F. et al. Betibeglogene autotemcel gene therapy for non-0\/0 genotype -thalassemia. N. Engl. J. Med. 386, 415427 (2022). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Malech, H. L. et al. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc. Natl Acad. Sci. USA 94, 1213312138 (1997). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Morgan, R. A., Gray, D., Lomova, A. & Kohn, D. B. Hematopoietic stem cell gene therapy: progress and lessons learned. Cell Stem Cell 21, 574590 (2017). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Sago, C. D. et al. Nanoparticles that deliver RNA to bone marrow identified by in vivo directed evolution. J. Am. Chem. Soc. 140, 1709517105 (2018). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Shi, D., Toyonaga, S. & Anderson, D. G. In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles. Nano Lett. 23, 29382944 (2023). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Sou, K., Goins, B., Oyajobi, B. O., Travi, B. L. & Phillips, W. T. Bone marrow-targeted liposomal carriers. Expert Opin. Drug Deliv. 8, 317328 (2011). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Sou, K., Klipper, R., Goins, B., Tsuchida, E. & Phillips, W. T. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute. J. Pharmacol. Exp. Ther. 312, 702709 (2005). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Xue, L. et al. Rational design of bisphosphonate lipid-like materials for mRNA delivery to the bone microenvironment. J. Am. Chem. Soc. 144, 99269937 (2022). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Boulais, P. E. & Frenette, P. S. Making sense of hematopoietic stem cell niches. Blood 125, 26212629 (2015). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Ikonomi, N., Kuhlwein, S. D., Schwab, J. D. & Kestler, H. A. Awakening the HSC: dynamic modeling of HSC maintenance unravels regulation of the TP53 pathway and quiescence. Front. Physiol. 11, 848 (2020). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Li, J. Quiescence regulators for hematopoietic stem cell. Exp. Hematol. 39, 511520 (2011). <\/p>\n

Article PubMed Google Scholar <\/p>\n

Man, Y., Yao, X., Yang, T. & Wang, Y. Hematopoietic stem cell niche during homeostasis, malignancy, and bone marrow transplantation. Front. Cell Dev. Biol. 9, 621214 (2021). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Nakamura-Ishizu, A., Takizawa, H. & Suda, T. The analysis, roles and regulation of quiescence in hematopoietic stem cells. Development 141, 46564666 (2014). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Eppert, K. et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 17, 10861093 (2011). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645648 (1994). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Mandal, T., Beck, M., Kirsten, N., Linden, M. & Buske, C. Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticles. Sci. Rep. 8, 989 (2018). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Pei, S. & Jordan, C. T. How close are we to targeting the leukemia stem cell? Best Pract. Res. Clin. Haematol. 25, 415418 (2012). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Li, C. et al. Prophylactic in vivo hematopoietic stem cell gene therapy with an immune checkpoint inhibitor reverses tumor growth in syngeneic mouse tumor models. Cancer Res. 80, 549560 (2020). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Li, C. et al. In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal globin in beta-YAC mice. Blood Adv. 5, 11221135 (2021). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Li, C. et al. In vivo HSC gene therapy using a bi-modular HDAd5\/35++ vector cures sickle cell disease in a mouse model. Mol. Ther. 29, 822837 (2021). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Li, C. et al. Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5\/35++ vectors. Mol. Ther. Methods Clin. Dev. 24, 127141 (2022). <\/p>\n

Article PubMed Google Scholar <\/p>\n

Psatha, N. et al. Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo. Blood 138, 15401553 (2021). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Muruve, D. A., Barnes, M. J., Stillman, I. E. & Libermann, T. A. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10, 965976 (1999). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Sweeney, C. L. & De Ravin, S. S. The promise of in vivo HSC prime editing. Blood 141, 20392040 (2023). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Worgall, S., Wolff, G., Falck-Pedersen, E. & Crystal, R. G. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8, 3744 (1997). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Lek, A. et al. Death after high-dose rAAV9 gene therapy in a patient with Duchennes muscular dystrophy. N. Engl. J. Med. 389, 12031210 (2023). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 10781094 (2021). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat. Nanotechnol. 15, 313320 (2020). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl Acad. Sci. USA 118, e2109256118 (2021). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Dilliard, S. A. & Siegwart, D. J. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat. Rev. Mater. 8, 282300 (2023). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Farbiak, L. et al. All-in-one dendrimer-based lipid nanoparticles enable precise HDR-mediated gene editing in vivo. Adv. Mater. 33, e2006619 (2021). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Liu, S. et al. Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing. Nat. Mater. 20, 701710 (2021). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Liu, S. et al. Zwitterionic phospholipidation of cationic polymers facilitates systemic mRNA delivery to spleen and lymph nodes. J. Am. Chem. Soc. 143, 2132121330 (2021). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Wang, X. et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nat. Protoc. 18, 265291 (2023). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Wei, T., Cheng, Q., Min, Y. L., Olson, E. N. & Siegwart, D. J. Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing. Nat. Commun. 11, 3232 (2020). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Zhang, D. et al. Enhancing CRISPR\/Cas gene editing through modulating cellular mechanical properties for cancer therapy. Nat. Nanotechnol. 17, 777787 (2022). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Wu, L. C. et al. Correction of sickle cell disease by homologous recombination in embryonic stem cells. Blood 108, 11831188 (2006). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Metais, J. Y. et al. Genome editing of HBG1 and HBG2 to induce fetal hemoglobin. Blood Adv. 3, 33793392 (2019). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Newby, G. A. et al. Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature 595, 295302 (2021). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Stavropoulou, V., Peters, A. & Schwaller, J. Aggressive leukemia driven by MLL-AF9. Mol. Cell Oncol. 5, e1241854 (2018). <\/p>\n

Article PubMed Google Scholar <\/p>\n

Hou, X. et al. Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis. Nat. Nanotechnol. 15, 4146 (2020). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

<\/p>\n

Read more:
\nBone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells - Nature.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Laurenti, E. & Gottgens, B. From haematopoietic stem cells to complex differentiation landscapes. Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-1125189","post","type-post","status-publish","format-standard","hentry","category-genome"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1125189"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=1125189"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1125189\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=1125189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=1125189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=1125189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}